Clinical trials remain the cornerstone of evidence-based medicine, yet they are frequently protracted and costly. More often than commonly thought, clinical trials are also uninformative.1 Artificial ...

A new AI medical receptionist offers potential to reduce clinical workload and empathetically engage with patients, according ...

Tempus AI is a growth stock that is down 31% from all-time highs. Here's why TEM AI stock could be a part of your TFSA portfolio right now. The post I’d Put My Entire 2025 TFSA Contribution Into This ...

From expanding interoperability efforts to building AI agents, here is a look at EHR vendor Oracle Health’s biggest moves so far in 2025, as reported by Becker’s: ...

Common Sense Media found that over 70% of teens have used AI companions, with many finding the interactions as satisfying as ...

As hype accelerates, it is important to look beyond the headlines and focus on the real economic trends behind this boom.

M42 is already the largest health care group in the Middle East and serves some 15 million patients worldwide with operations in 27 countries. Its revenues have grown five times in the past seven ...

Bonilla, MD, MSEd, discusses the significant advancements and ongoing efforts in integrating artificial intelligence into oncology.

It’s a sentiment felt widely across the medical field as AI starts to touch nearly every corner of medical research, physician training and processes, and patient care. The rollout of AI across health ...

Four health systems participated in a $150 million funding round for clinical artificial intelligence company Aidoc. The round, led by General Catalyst and Square Peg, aims to accelerate development ...

Language technologies are being adapted for health across Africa. But most of these tools never make it beyond the lab or ...